ResearcherZhejiang Chinese Medical UniversityActive in the last 2 years
Hangbin Jin
Matched on OpenAlex author ID A5109450463. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 2 papers · 2025: 2 papers
Papers 5
- Targeting RhoA expression with formononetin and salvianolic acid B to mitigate pancreatic cancer-associated endothelial cells changes. First author DOI 10.1016/j.jep.2024.118711↗
- Complex interplay between type 2 diabetes mellitus and pancreatic cancer: insights from observational and mendelian randomization analyses. Co-author DOI 10.1186/s12885-025-13976-6↗
- Hyperthermia improves gemcitabine sensitivity of pancreatic cancer cells by suppressing the EFNA4/β-catenin axis and activating dCK. Last author DOI 10.1016/j.heliyon.2024.e28488↗
- Global research trends and hotspots between pancreatic cancer and diabetes from2004 to 2024: A bibliometric analysis Co-author DOI 10.21203/rs.3.rs-4198735/v1↗
- Hyperthermia inhibits the motility of gemcitabine-resistant pancreatic cancer PANC-1 cells through the inhibition of epithelial-mesenchymal transition. Co-author DOI 10.3892/mmr.2018.8763↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xiaofeng Zhang · 4 shared papers, 2024–2025 · strength 1.02
- Paper Targeting RhoA expression with formononetin and salvianolic acid B to mitigate pancreatic cancer-associated endothelial… DOI 10.1016/j.jep.2024.118711↗
- Paper Complex interplay between type 2 diabetes mellitus and pancreatic cancer: insights from observational and mendelian ran… DOI 10.1186/s12885-025-13976-6↗
- Paper Hyperthermia improves gemcitabine sensitivity of pancreatic cancer cells by suppressing the EFNA4/β-catenin axis and ac… DOI 10.1016/j.heliyon.2024.e28488↗
- Yuxin Wang · 2 shared papers, 2024–2025 · strength 0.51
- Paper Complex interplay between type 2 diabetes mellitus and pancreatic cancer: insights from observational and mendelian ran… DOI 10.1186/s12885-025-13976-6↗
- Paper Global research trends and hotspots between pancreatic cancer and diabetes from2004 to 2024: A bibliometric analysis DOI 10.21203/rs.3.rs-4198735/v1↗
- Weigang Gu · 2 shared papers, 2024 · strength 0.46
- Paper Hyperthermia improves gemcitabine sensitivity of pancreatic cancer cells by suppressing the EFNA4/β-catenin axis and ac… DOI 10.1016/j.heliyon.2024.e28488↗
- Paper Global research trends and hotspots between pancreatic cancer and diabetes from2004 to 2024: A bibliometric analysis DOI 10.21203/rs.3.rs-4198735/v1↗
- Jianfeng Yang · 2 shared papers, 2018–2025 · strength 0.38
- Paper Targeting RhoA expression with formononetin and salvianolic acid B to mitigate pancreatic cancer-associated endothelial… DOI 10.1016/j.jep.2024.118711↗
- Paper Hyperthermia inhibits the motility of gemcitabine-resistant pancreatic cancer PANC-1 cells through the inhibition of ep… DOI 10.3892/mmr.2018.8763↗
- Yu Wang · 1 shared paper, 2025 · strength 0.28
- Yan Chen · 1 shared paper, 2025 · strength 0.28
- Qiang Liu · 1 shared paper, 2025 · strength 0.28
- Qiaoxian He · 1 shared paper, 2024 · strength 0.23
- Hongzhang Shen · 1 shared paper, 2024 · strength 0.23
- Shirong Zhang · 1 shared paper, 2018 · strength 0.10
- Shenglin Ma · 1 shared paper, 2018 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.